Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ProclaRx

ProclaRx
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Conv. Debt LATEST DEAL TYPE
$512K LATEST DEAL AMOUNT
1 INVESTORS
Description

Provider of therapeutics designed to develop and commercialize anti-bacterial biofilm IP technology. The company's therapeutics are mainly for biofilm associated chronic and recurrent bacterial infections and offers bacterial biofilm disruption mechanism, enabling physicians to optimize our commercialization pathways while keeping costs low.

Formerly Known As
Lattice Biotech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • Suite 212
  • 340 West State Street
  • Athens, OH 45701
  • United States

+1 (614) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ProclaRx’s full profile, request a free trial.

ProclaRx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Convertible Debt 27-Feb-2017 $512K 00.000 Completed Startup
1. Angel (individual) 12-Jan-2016 00.00 00.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ProclaRx Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mironid Venture Capital-Backed Newhouse, United Kingdom 0 000.00 0000000000 0 000.00
00000000 Formerly VC-backed South San Francisco, CA 00 00000 0000000000.
00000000 000000000 Venture Capital-Backed Vienna, Austria 00.000 0000000000 00.000
000000 000000 Venture Capital-Backed South San Francisco, CA 0 00.00 000000000000 00.00
000000000-00 Venture Capital-Backed Cambridge, United Kingdom 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

ProclaRx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
TechGROWTH Ohio Venture Capital Minority 000 0000 000000 0

ProclaRx Executive Team (4)

Name Title Board
Seat
Contact
Info
Joseph Kittle Jr. Chief Executive Officer
Tom Zupancic Ph.D Co-Founder & Chief Scientific Officer
Rich Brody Ph.D Vice President of Research & Development

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

ProclaRx Board Members (1)

Name Representing Role Since Contact
Info
Nick Henderson Self Chairman 000 0000